Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office
This latest granted patent in Macau, a special administrative region of China, further strengthens Clearmind’s global intellectual property portfolio, which now includes 31 granted patents across 18 ...
Clearmind Medicine granted patent for binge behavior treatment by Macau
Clearmind Medicine (CMND) announces advancement in its proprietary MEAI- based binge behavior regulator program through the granting of patent ...
Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial
Vancouver, Canada, Dec. 24, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel ...
Clearmind Medicine to move forward with MEAI-based alcohol substitute
Clearmind Medicine (CMND) recently announced that it signed a non-binding term sheet with Dr. Glitter Pty Ltd, a health ...
Clearmind Medicine receives IRB approval for Phase I/IIa clinical trial of CMND-100
Biotech company Clearmind Medicine (CMND) has received the approval of the Institutional Review Board for its Phase I/IIa clinical trial of CMND-100, targeting alcohol use disorder.
Nasdaq10d
Clearmind Medicine Inc. Receives IRB Approval for Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder
Clearmind Medicine Inc., a clinical-stage biotech company focused on psychedelic-derived therapeutics, has announced the receipt of Institutional Review Board approval for its Phase I/IIa clinical ...
Nasdaq8d
Clearmind Medicine Inc. Partners with Dr. Glitter Pty Ltd for Development of MEAI-Based Alcohol Alternative in ActivCrystal™ Format
Clearmind Medicine Inc. has signed a non-binding term sheet with Dr. Glitter Pty Ltd to collaborate on the development of a proprietary alcohol substitute based on MEAI technology, utilizing Dr ...
Clearmind Medicine Inc.: Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial
Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development ...
Morningstar10d
Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial
Vancouver, Canada, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech ...
Why Is Penny Stock Clearmind Gaining Today?
Clearmind Medicine's stock rose 63.9% after receiving IRB approval for its Phase I/IIa trial of CMND-100, a drug for alcohol ...
Morningstar8d
Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute
Company recently signed a non-binding term sheet with Dr Glitter Pty Ltd for mutual development in ActivCrystal™ Format Vancouver, Canada, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine ...
Clearmind Medicine Shares Double on Trial Approval
Shares of Clearmind Medicine more than doubled after the Institutional Review Board approved a clinical trial of its flagship compound as a treatment for alcohol use disorder. The stock was changing ...